Preliminary analysis of patient disease outcome appears to suggest that IgM detection rates were substantially lower in those that progressed to severe pneumonia (33.3%, 2/6), as opposed to mild disease (89.7%, 35/39) (Figure 1C). This evidence concerns the gene CD40LG and pneumonia.